Maxcyte, Inc.
Maxcyte develops Flow Electroporation technology for engineering cells in cell and gene therapy discovery and development.
424B3Sep 4Latest SEC filing
Aug 12Latest story
August 2026
Maxcyte develops Flow Electroporation technology for engineering cells in cell and gene therapy discovery and development.